{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:54:57Z","timestamp":1790268897403,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Novartis Pharmaceutical Corp"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.anai.2011.09.008","type":"journal-article","created":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T03:30:59Z","timestamp":1320291059000},"page":"20-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria"],"prefix":"10.1016","volume":"108","author":[{"given":"Susan D.","family":"Mathias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross D.","family":"Crosby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Zazzali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarbjit S.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2011.09.008_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","article-title":"Unmet clinical needs in chronic spontaneous urticaria: A GA(2)LEN task force report","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2011.09.008_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12019-001-0017-1","article-title":"Chronic idiopathic urticaria","volume":"27","author":"Demera","year":"2001","journal-title":"Compr Ther"},{"key":"10.1016\/j.anai.2011.09.008_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.anai.2010.06.011","article-title":"Development of a daily diary for patients with chronic idiopathic urticaria","volume":"105","author":"Mathias","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2011.09.008_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1398-9995.2008.01920.x","article-title":"The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings","volume":"64","author":"Mlynek","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2011.09.008_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2133.1997.d01-1168.x","article-title":"The impact of chronic urticaria on the quality of life","volume":"136","author":"O'Donnell","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anai.2011.09.008_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archdermatol.2007.6","article-title":"Chronic idiopathic urticaria: a \u201cCinderella\u201d disease with a negative impact on quality of life and health care costs","volume":"144","author":"Yosipovitch","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anai.2011.09.008_bib7","doi-asserted-by":"crossref","first-page":"e14794","DOI":"10.1371\/journal.pone.0014794","article-title":"IgE mediated autoallergy against thyroid peroxidase: a novel pathomechanism of chronic spontaneous urticaria?","volume":"6","author":"Altrichter","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.anai.2011.09.008_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jaci.2011.04.038","article-title":"Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase","volume":"128","author":"Maurer","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2011.09.008_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1398-9995.2008.01726.x","article-title":"How to assess disease activity in patients with chronic urticaria?","volume":"63","author":"Mlynek","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2011.09.008_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.06.010","article-title":"A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria","volume":"128","author":"Saini","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2011.09.008_bib11","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.anai.2011.09.008_bib12","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/0895-4356(95)00054-2","article-title":"Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis","volume":"48","author":"Stucki","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.anai.2011.09.008_bib13","first-page":"889","article-title":"Measuring disease-specific quality of life in clinical trials","volume":"134","author":"Guyatt","year":"1986","journal-title":"CMAJ"},{"key":"10.1016\/j.anai.2011.09.008_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0895-4356(99)00071-2","article-title":"Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life","volume":"52","author":"Wyrwich","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.anai.2011.09.008_bib16","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/00005650-199811000-00008","article-title":"Changes in the SF-36 in 12 months in a clinical sample of disadvantaged older adults","volume":"36","author":"Wolinsky","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.anai.2011.09.008_bib17","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0895-4356(97)00097-8","article-title":"Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach","volume":"50","author":"Norman","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.anai.2011.09.008_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0895-4356(03)00044-1","article-title":"Defining clinically meaningful change in health-related quality of life","volume":"56","author":"Crosby","year":"2003","journal-title":"J Clin Epidemiol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120611006946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120611006946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:05:31Z","timestamp":1761051931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120611006946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1081120611006946"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2011.09.008","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717948557.793453612","asserted-by":"object"}]},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2011.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}